Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The electroencephalographic (EEG) effects of drugs interacting with dopaminergic and noradrenergic systems were studied in conscious rats. Power spectra (0–30 Hz) were recorded from electrodes implanted bilaterally in the prefrontal cortex. Drug effects on EEG power were calculated as the spectral power following drug administration divided by the spectral power after vehicle administration. Dopaminergic agonists at low doses, (apomorphine 0.01 mg kg−1 s.c., quinpirole 0.01 mg kg−1 i.p.) and dopaminergic antagonists (haloperidol 1 mg kg−1 i.p., raclopride 2.5 mg kg−1 s.c.), which decrease dopaminergic transmission, induced an increase of EEG power. Conversely, dopaminergic agonists at higher doses (apomorphine 0.5 mg kg−1 s.c., quinpirole 0.5 mg kg−1 i.p.) which increase activation of postsynaptic D 2 and D 3 receptors, induced a decrease of EEG power. The α 1‐adrenoceptor antagonists (phenoxybenzamine 0.64 mg kg−1 s.c., prazosin 0.32 mg kg−1 s.c.) and the α 2‐adrenoceptor agonists (UK 14304 0.05 mg kg−1 s.c., clonidine 0.025 mg kg−1 i.p.), which decrease noradrenergic transmission, induced an increase of EEG power. Conversely, the α 1‐adrenoceptor agonist, cirazoline (0.05 mg kg−1 s.c.), the adrenergic agent modafinil (250, 350 mg kg−1 i.p.) and α 2‐adrenoceptor antagonists (RX 821002 0.01 mg kg−1 s.c., yohimbine 0.5 mg kg−1 i.p.), which increase noradrenergic transmission, induced a decrease of EEG power. The effects of prazosin (0.64 mg kg−1 s.c.) were dose‐dependently antagonized by co‐administration with modafinil and cirazoline, but not by apomorphine. In conclusion, pharmacological modulation of dopaminergic and noradrenergic transmission may result in consistent EEG changes: decreased dopaminergic or noradrenergic activity induces an increase of EEG spectral power; while increased dopaminergic or noradrenergic activity decreases EEG spectral power. British Journal of Pharmacology (1999) 128, 1045–1054; doi:10.1038/sj.bjp.0702894
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thalamocortical oscillations in the sleeping and aroused brain
Steriade, M., McCormick, D. A., & Sejnowski, T. J. (1993) · Science · doi:10.1126/science.8235588 · Cited by 3,564 · cited 8×
“…by dopaminergic agonists and antagonists, a1- and a2-adrenoceptor agonists and antagonists respectively, it must be emphasized that global EEG activity re¯ects a variety of oscillations generated in the thalamus and cerebral cortex (Bradshaw et al., 1983; Gaillard, 1990; Steriade et al., 1993c).”
BackgroundInfluential
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Self-citationThe involvement of dopamine in the modulation of sleep and waking
Monti, J. M., & Monti, D. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.08.003 · Cited by 415
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking
MONTI, J., & JANTOS, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00929-1 · Cited by 302
Electrophysiological changes during adolescence: A review
Segalowitz, S. J., Santesso, D. L., & Jetha, M. K. (2010) · Brain and Cognition · doi:10.1016/j.bandc.2009.10.003 · Cited by 269
Tuning pathological brain oscillations with neurofeedback: a systems neuroscience framework
Ros, T., J. Baars, B., Lanius, R. A., & Vuilleumier, P. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.01008 · Cited by 258
Metadata
- Authors
- Sebban, C., Zhang, X. Q., Tesolin‐Decros, B., Millan, M. J., & Spedding, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-11
- Volume
- 128
- Issue
- 5
- Pages
- 1045-1054
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2069218117
- Cited by
- 81
- References
- 1
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. https://app.cochat.ai/papers/10.1038/sj.bjp.0702894
- The paper
- Sebban, C., Zhang, X. Q., Tesolin‐Decros, B., Millan, M. J., & Spedding, M. (1999). Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0702894
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.